Autoimmune Intervention Mastery Course Study

RECRUITING

I'm interested ...!!

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remission with persisting fatigue.

Conditions:

Multiple Sclerosis Clinically Isolated Syndrome Fibromyalgia Post Acute Sequelae of COVID-19 Cancer in Remission With Persisting Fatigue

Study Start (Actual) 2021-12-01

Primary Completion (Estimated) 2026-12-01

Study Completion (Estimated) 2026-12-01

Enrollment (Estimated) 80

Study Type INTERVENTIONAL

Phase NA

Locations:

📍 Iowa City, Iowa, United States

Eligibility Criteria

Description

Inclusion Criteria:

* self-reported multiple sclerosis
* self-reported clinically isolated syndrome
OR self-reported post-acute sequelae of COVID (PASC), also known as long COVID, with a confirmed laboratory test of COVID-19 infection, persisting fatigue and neuropsychiatric symptoms for longer than 6 months after confirmation of COVID diagnosis,
OR self-reported diagnosis of fibromyalgia as documented by their treating specialist or primary care provider,

Exclusion Criteria:

Ages Eligible for Study: 18 Years to 100 Years (ADULT, OLDER_ADULT)

Sexes Eligible for Study: ALL

Accepts Healthy Volunteers: No

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted2021-09-15
First Submitted that Met QC Criteria2021-09-15
First Posted2021-09-27

Study Record Updates

Last Update Submitted that Met QC Criteria2024-07-22
Last Update Posted2024-07-24
Last Verified2024-07